Discover 1,443 paid clinical trials in St. Petersburg, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,443
A Study of DS5361b in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Sarasota FL, Fairfax VA, Irving TX, San Antonio TX,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT07182591
Phase1, Recruiting
Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty
Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC
for
Squamous Cell Carcinoma, Head and Neck Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT06137274
Phase2, Recruiting
Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
for
Thyroid Carcinoma
Location: Sarasota FL, Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07218315
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment
for
Pregnant Individuals, Aneuploidy, Down Syndrome (Trisomy 21),
Location: Sarasota FL, Atlanta GA, Baton Rouge LA, Houston TX,
Sponsor: BillionToOne Inc.
Sex: Female
Age: 0+
Code: NCT07643896
Recruiting
Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System
for
Thyroid Nodule, Thyroid Goiter, Ablation
Location: Sarasota FL, New York NY
Sponsor: Pulse Biosciences, Inc.
Sex: All
Age: 22 - 70+
Code: NCT07287176
Recruiting
Breast Cancer Liquid Biopsy Trial
for
Breast Cancer, Cancer
Location: Sarasota FL, Orlando FL, Ocala FL, Hollywood FL,
Sponsor: Anthony Magliocco
Sex: All
Age: 18+
Code: NCT04962529
Recruiting
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
for
Paroxysmal Atrial Fibrillation
Location: Sarasota FL, Mobile AL, Atlanta GA, Birmingham AL,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Sex: All
Age: 18+
Code: NCT06324201
Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Sarasota FL, West Palm Beach FL, Miami Beach FL,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06824467
Phase3, Recruiting
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: Sarasota FL, Atlanta GA, Myrtle Beach SC, Nashville TN,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06545955
Phase3, Recruiting
The PERSEVERE Study
for
Pulmonary Embolism, Pulmonary Thromboembolism
Location: Sarasota FL, Orlando FL, Atlanta GA, Jackson MS,
Sponsor: Inari Medical
Sex: All
Age: 18+
Code: NCT06588634
Recruiting
US Post-Market Surveillance Study of the Surfacer System
for
Venous Disease
Location: Sarasota FL, Atlanta GA, Norfolk VA, Houston TX,
Sponsor: Merit Medical Systems, Inc.
Sex: All
Age: 18+
Code: NCT05050799
Recruiting
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy